As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The recent success of angiotensin receptor blocker (ARB) drugs such as telmisartan can be attributed to the tentative utilisation of the drug in the treatment of COVID-19 infected patients. The clinical trials on people aged 18+ showed significant results in the treatment of COVID-19 with a lower median time to discharge, from 15 days to 9 days, reduction in deaths, and a substantial reduction in the requirement of ventilation, along with no side effects. The study suggested that the drug is safe and could reduce morbidity and mortality in critically infected patients. In addition to this, telmisartan is used for treating chronic diseases like hypertension, thereby lowering the risk of stroke and cardiac arrests, which is continually delivering a positive influence on the industry growth.
The presence of online healthcare platforms, including 1mg, Netmeds, and PharmEasy, are creating growth opportunities for the wide reach of telmisartan drugs. Telmisartan is popularly used to treat chronic diseases like hypertension and other cardiovascular diseases. In the presence of these online channels, companies like Nippon Boehringer Ingelheim, and Pfizer, Inc (NYSE: PFE). among others, are able to make their products available worldwide. Thus, the existence of online delivery channels is boosting the sales of telmisartan and hence augmenting the industry growth.
Market Analysis by Strength, Condition, Distribution Channel, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global telmisartan market are Novartis AG, Astellas Pharma Inc., Nippon Boehringer Ingelheim, Abbott, Hema Pharmaceuticals Pvt. Ltd., and Pfizer Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.